Financial Instruments (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Marketable Securities Measured at Fair Value on a Recurring Basis |
The following tables summarize our cash, cash equivalents, and marketable securities measured at fair value on a recurring basis (in millions): | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Total | Cash | | | | | | $ | 15,305 | | Cash equivalents: | | | | | | | Money market funds | | $ | 11,349 | | | $ | 0 | | | $ | 11,349 | | Time deposits | | 0 | | | 3,353 | | | 3,353 | | | Government bonds | | 0 | | | 602 | | | 602 | | | Corporate debt securities | | 0 | | | 99 | | | 99 | | Total cash and cash equivalents | | 11,349 | | | 4,054 | | | 30,708 | | Marketable securities: | | | | | | | Marketable equity securities | | 4,402 | | 1,911 | | 6,313 | | Government bonds | | 0 | | 50,549 | | 50,549 | | Corporate debt securities | | 0 | | 21,565 | | 21,565 | | Mortgage-backed and asset-backed securities | | 0 | | 17,708 | | 17,708 | Total marketable securities | | 4,402 | | | 91,733 | | | 96,135 | | | Total | | $ | 15,751 | | | $ | 95,787 | | | $ | 126,843 | |
| | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2026 | | | Quoted Prices in Active Markets for Identical Assets (Level 1) | | Significant Other Observable Inputs (Level 2) | | Total | | Cash | | | | | | $ | 15,695 | | | Cash equivalents: | | | | | | | Money market funds | | $ | 13,810 | | | $ | 0 | | | $ | 13,810 | | Time deposits | | 0 | | | 5,080 | | | 5,080 | | | Government bonds | | 0 | | | 21,718 | | | 21,718 | | | Corporate debt securities | | 0 | | | 31 | | | 31 | | Total cash and cash equivalents | | 13,810 | | | 26,829 | | | 56,334 | | | Marketable securities: | | | | | | | Marketable equity securities(1) | | 89,919 | | 465 | | 90,384 | | Government bonds | | 0 | | 68,629 | | 68,629 | | Corporate debt securities | | 0 | | 27,054 | | 27,054 | | Mortgage-backed and asset-backed securities | | 0 | | 22,697 | | 22,697 | Total marketable securities | | 89,919 | | | 118,845 | | | 208,764 | | | Total | | $ | 103,729 | | | $ | 145,674 | | | $ | 265,098 | |
(1) Includes $75.2 billion of Space Exploration Technologies Corp. ("SpaceX") shares subject to short-term restrictions on the ability to sell.
|
| Schedule of Investments by Maturity Date |
The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates (in millions): | | | | | | | As of September 30, 2026 | | Due in 1 year or less | $ | 16,997 | | | Due in 1 year through 5 years | 66,478 | | | Due in 5 years through 10 years | 17,508 | | | Due after 10 years | 17,397 | | | Total | $ | 118,380 | |
|
| Schedule of Available-for-Sale Debt Securities |
The following tables present fair values and gross unrealized gains and losses recorded to accumulated other comprehensive income (AOCI), less any expected credit losses, aggregated by investment category (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Time deposits | | $ | 3,353 | | | $ | 0 | | | $ | 0 | | | $ | 3,353 | | | Government bonds | | 49,087 | | 443 | | | (26) | | | 49,504 | | | Corporate debt securities | | 18,346 | | | 242 | | | (32) | | | 18,556 | | | Mortgage-backed and asset-backed securities | | 14,337 | | | 174 | | | (128) | | | 14,383 | | Total investments with fair value change reflected in other comprehensive income | | $ | 85,123 | | | $ | 859 | | | $ | (186) | | | $ | 85,796 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2026 | | | Adjusted Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Time deposits | | $ | 5,080 | | | $ | 0 | | | $ | 0 | | | $ | 5,080 | | | Government bonds | | 89,823 | | 2 | | | (1,371) | | | 88,454 | | | Corporate debt securities | | 24,308 | | | 15 | | | (425) | | | 23,898 | | | Mortgage-backed and asset-backed securities | | 20,647 | | | 17 | | | (780) | | | 19,884 | | Total investments with fair value change reflected in other comprehensive income | | $ | 139,858 | | | $ | 34 | | | $ | (2,576) | | | $ | 137,316 | |
|
| Schedule of Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value |
The following tables present fair values and gross unrealized losses recorded to AOCI, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | Less than 12 Months | | 12 Months or Greater | | Total | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Government bonds | $ | 4,230 | | | $ | (9) | | | $ | 1,174 | | | $ | (17) | | | $ | 5,404 | | | $ | (26) | | | Corporate debt securities | 915 | | | 0 | | | 2,429 | | | (24) | | | 3,344 | | | (24) | | | Mortgage-backed and asset-backed securities | 1,377 | | | (4) | | | 3,035 | | | (124) | | | 4,412 | | | (128) | | | Total | $ | 6,522 | | | $ | (13) | | | $ | 6,638 | | | $ | (165) | | | $ | 13,160 | | | $ | (178) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2026 | | Less than 12 Months | | 12 Months or Greater | | Total | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Fair Value | | Unrealized Loss | | Government bonds | $ | 62,455 | | | $ | (1,336) | | | $ | 720 | | | $ | (35) | | | $ | 63,175 | | | $ | (1,371) | | | Corporate debt securities | 20,095 | | | (290) | | | 778 | | | (6) | | | 20,873 | | | (296) | | | Mortgage-backed and asset-backed securities | 17,464 | | | (625) | | | 1,486 | | | (155) | | | 18,950 | | | (780) | | | Total | $ | 100,014 | | | $ | (2,251) | | | $ | 2,984 | | | $ | (196) | | | $ | 102,998 | | | $ | (2,447) | |
|
| Schedule of Gains and Losses on Equity Securities |
The following table summarizes gains and losses for debt securities, reflected as a component of OI&E (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, | | September 30, | | 2025 | | 2026 | | 2025 | | 2026 | | Unrealized gain (loss) on fair value option debt securities | $ | 15 | | | $ | (243) | | | $ | 242 | | | $ | (357) | | | Gross realized gain on debt securities | 135 | | | 24 | | | 485 | | | 172 | | | Gross realized loss on debt securities | (30) | | | (81) | | | (268) | | | (219) | | | (Increase) decrease in allowance for credit losses | 2 | | | (83) | | | 30 | | | (122) | | | Total gain (loss) on debt securities recognized in other income (expense), net | $ | 122 | | | $ | (383) | | | $ | 489 | | | $ | (526) | |
Gains and losses (including impairments), net, for equity securities included in OI&E are summarized below (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, | | September 30, | | 2025 | | 2026 | | 2025 | | 2026 | Gross unrealized gain on non-marketable equity securities accounted for under the measurement alternative | $ | 10,583 | | | $ | 3,386 | | | $ | 20,924 | | | $ | 117,203 | | Gross unrealized loss (including impairments) on non-marketable equity securities accounted for under the measurement alternative | (346) | | | (359) | | | (1,188) | | | (887) | | Unrealized net gain (loss) on non-marketable equity securities accounted for under the measurement alternative | 10,237 | | | 3,027 | | | 19,736 | | | 116,316 | | Unrealized net gain (loss) on marketable and other equity securities | 447 | | | (12,436) | | | 1,447 | | | 9,377 | | Realized net gain (loss) on marketable and non-marketable equity securities sold during the period | 50 | | | 745 | | | 595 | | | 1,589 | | Total gain (loss) on equity securities in other income (expense), net (1) | $ | 10,734 | | | $ | (8,664) | | | $ | 21,778 | | | $ | 127,282 | |
(1)Excludes income (loss) and impairment from equity method investments. See Note 7 for further details.
|
| Schedule of Non-Marketable Securities |
The carrying values for non-marketable securities are summarized below (in millions): | | | | | | | | | | | | | | | As of December 31, 2025 | | As of September 30, 2026 | Non-marketable securities: | | | | | Total initial cost of non-marketable equity securities accounted for under the measurement alternative | | $ | 28,429 | | | $ | 48,595 | | Cumulative upward adjustments | | 44,485 | | | 88,784 | | Cumulative downward adjustments (including impairments) | | (8,820) | | | (9,210) | | Carrying value of non-marketable equity securities accounted for under the measurement alternative(1) | | 64,094 | | | 128,169 | | Equity method investments and other | | 4,593 | | | 7,061 | | Total non-marketable securities | | $ | 68,687 | | | $ | 135,230 | |
(1) As of September 30, 2026, our investments in non-marketable securities accounted for under the measurement alternative primarily consist of our investment in one private company.
|
| Schedule of Gross Notional Amounts of Derivative Instruments |
The gross notional amounts of outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | As of December 31, 2025 | | As of September 30, 2026 | Derivatives designated as hedging instruments: | | | | Foreign exchange derivatives | | | | | Cash flow hedges | $ | 23,852 | | | $ | 25,141 | | | Net investment hedges | $ | 14,203 | | | $ | 6,987 | | | Interest rate derivatives | | | | | Fair value hedges | $ | 0 | | | $ | 7,000 | | | Derivatives not designated as hedging instruments: | | | Foreign exchange derivatives | $ | 56,085 | | | $ | 54,084 | | Equity derivatives | $ | 0 | | | $ | 21,091 | | Credit derivatives | $ | 16,940 | | | $ | 48,012 | | | Other derivatives | $ | 15,900 | | | $ | 11,420 | |
|
| Schedule of Derivative Instruments |
The fair values of outstanding derivative instruments were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | As of September 30, 2026 | | Assets(1) | | Liabilities(2) | | Assets(1) | | Liabilities(2) | | Derivatives designated as hedging instruments: | | | | | | | | Foreign exchange derivatives | $ | 316 | | | $ | 197 | | | $ | 501 | | | $ | 64 | | | | | | | | | | | Interest rate derivatives | 0 | | 0 | | 1 | | 257 | | Total derivatives designated as hedging instruments | $ | 316 | | | $ | 197 | | | $ | 502 | | | $ | 321 | | | Derivatives not designated as hedging instruments: | | | | | | | | Foreign exchange derivatives | 92 | | 15 | | 117 | | 240 | | Equity derivatives | 0 | | 0 | | 579 | | 445 | Credit derivatives | 0 | | 69 | | 0 | | 606 | Other derivatives | 324 | | 98 | | 107 | | 24 | | Total derivatives not designated as hedging instruments | 416 | | | 182 | | | 803 | | | 1,315 | | | Total | $ | 732 | | | $ | 379 | | | $ | 1,305 | | | $ | 1,636 | |
(1) Derivative assets are recorded as other current and non-current assets. (2) Derivative liabilities are recorded as accrued expenses and other liabilities, current and non-current.
|
| Schedule of Fair Value Hedging Instruments |
The amounts recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges were as follows (in millions): | | | | | | | | | | | | | As of December 31, 2025 | | As of September 30, 2026 | | Balance Sheets Line Item of the Hedged Item | | | | | Long-term debt | | | | | Carrying amount of the hedged item assets/(liabilities) | $ | 0 | | | $ | (6,688) | | | Cumulative amount of fair value hedging adjustment included in the carrying amount assets/(liabilities) | $ | 0 | | | $ | 257 | |
|
| Schedule of Gain (Loss) on Derivative Instruments |
The gains (losses) on derivatives and non-derivative financial instruments in cash flow hedging and net investment hedging relationships recognized in other comprehensive income are summarized below (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, | | September 30, | | 2025 | | 2026 | | 2025 | | 2026 | Cash flow hedging relationship: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Amount included in the assessment of effectiveness | $ | 278 | | | $ | (60) | | | $ | (1,111) | | | $ | 496 | | | Amount excluded from the assessment of effectiveness | 128 | | | 6 | | | (41) | | | 74 | | | | | | | | | | | Interest rate derivatives | | | | | | | | | Amount included in the assessment of effectiveness | 0 | | | 105 | | | $ | 0 | | | 105 | | Net investment hedging relationship: | | | | | | | | Amount included in the assessment of effectiveness | | | | | | | | | Foreign exchange derivatives | 55 | | | (103) | | | (794) | | | 404 | | | Foreign currency-denominated debt | 11 | | | 4 | | | (208) | | | 808 | | Amounts excluded from the assessment of effectiveness | | | | | | | | | Foreign exchange derivatives | 0 | | | 0 | | | 0 | | | (15) | | | Total | $ | 472 | | | $ | (48) | | | $ | (2,154) | | | $ | 1,872 | |
The table below presents the gains (losses) of derivatives included in the Consolidated Statements of Income: (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | 2025 | | 2026 | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | | Total amounts included in the Consolidated Statements of Income | $ | 102,346 | | | $ | 12,759 | | | $ | 127,577 | | | $ | (8,221) | | | | | | | | | | | Effect of cash flow hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | Amount included in the assessment of effectiveness | $ | (237) | | | $ | 0 | | | $ | 196 | | | $ | 0 | | Amount excluded from the assessment of effectiveness | 30 | | | 0 | | | (2) | | | 0 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Effect of fair value hedges: | | | | | | | | | Interest rate derivatives | | | | | | | | | Hedged items | 0 | | | 0 | | | 0 | | | 257 | | | Derivatives designated as hedging instruments | 0 | | | 0 | | | 0 | | | (257) | | | Effect of net investment hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Amount excluded from the assessment of effectiveness | 0 | | | 87 | | | 0 | | | 31 | | | Effect of non-designated hedges: | | | | | | | | | Foreign exchange derivatives | 0 | | | 76 | | | 0 | | | (286) | | | Equity derivatives | 0 | | | 0 | | | 0 | | | 83 | | | Credit derivatives | 0 | | | 0 | | | 0 | | | 277 | | | Other derivatives | 0 | | | 11 | | | 0 | | | 27 | | | Total gains (losses) | $ | (207) | | | $ | 174 | | | $ | 194 | | | $ | 132 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | 2025 | | 2026 | | Revenues | | Other income (expense), net | | Revenues | | Other income (expense), net | | Total amounts included in the Consolidated Statements of Income | $ | 289,007 | | | $ | 26,604 | | | $ | 357,269 | | | $ | 127,478 | | | | | | | | | | | Effect of cash flow hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Amount included in the assessment of effectiveness | $ | (133) | | | $ | 0 | | | $ | 82 | | | $ | 0 | | | Amount excluded from the assessment of effectiveness (amortized) | 73 | | | 0 | | | 38 | | | 0 | | | Effect of fair value hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Hedged items | 0 | | | (9) | | | 0 | | | 0 | | | Amount included in the assessment of effectiveness | 0 | | | 9 | | | 0 | | | 0 | | | Amount excluded from the assessment of effectiveness | 0 | | | 1 | | | 0 | | | 0 | | | Interest rate derivatives | | | | | | | | | Hedged items | 0 | | 0 | | 0 | | 257 | | Derivatives designated as hedging instruments | 0 | | 0 | | 0 | | (257) | | | Effect of net investment hedges: | | | | | | | | | Foreign exchange derivatives | | | | | | | | | Amount excluded from the assessment of effectiveness | 0 | | | 146 | | | 0 | | | 156 | | | Effect of non-designated hedges: | | | | | | | | | Foreign exchange derivatives | 0 | | | 321 | | | 0 | | | (1,067) | | | Equity derivatives | 0 | | | 0 | | | 0 | | | (296) | | | Credit derivatives | 0 | | | 0 | | | 0 | | | 200 | | | Other derivatives | 0 | | | (84) | | | 0 | | | 11 | | | Total gains (losses) | (60) | | | 384 | | | 120 | | | (996) | |
|
| Schedule of Offsetting Assets |
The gross amounts of derivative instruments subject to master netting arrangements with various counterparties, and cash and non-cash collateral received and pledged under such agreements were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | $ | 842 | | | $ | (110) | | | $ | 732 | | | $ | (140) | | | $ | (231) | | | $ | 361 | | | Derivatives liabilities | $ | 489 | | | $ | (110) | | | $ | 379 | | | $ | (140) | | | $ | (15) | | | $ | 224 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2026 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | Derivatives assets(1) | $ | 1,416 | | | $ | (111) | | | $ | 1,305 | | | $ | (322) | | | $ | (261) | | | $ | 722 | | | Derivatives liabilities | $ | 1,747 | | | $ | (111) | | | $ | 1,636 | | | $ | (322) | | | $ | (14) | | | $ | 1,300 | |
(1)The balances as of December 31, 2025 and September 30, 2026 were related to derivatives allowed to be net settled in accordance with our master netting agreements.
|
| Schedule of Offsetting Liabilities |
The gross amounts of derivative instruments subject to master netting arrangements with various counterparties, and cash and non-cash collateral received and pledged under such agreements were as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of December 31, 2025 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | | Derivatives assets | $ | 842 | | | $ | (110) | | | $ | 732 | | | $ | (140) | | | $ | (231) | | | $ | 361 | | | Derivatives liabilities | $ | 489 | | | $ | (110) | | | $ | 379 | | | $ | (140) | | | $ | (15) | | | $ | 224 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | As of September 30, 2026 | | | | | | | | Gross Amounts Not Offset in the Consolidated Balance Sheets, but Have Legal Rights to Offset | | | | Gross Amounts Recognized | | Gross Amounts Offset in the Consolidated Balance Sheets | | Net Amounts Presented in the Consolidated Balance Sheets | | Financial Instruments(1) | | Cash and Non-Cash Collateral Received or Pledged | | Net Amounts | Derivatives assets(1) | $ | 1,416 | | | $ | (111) | | | $ | 1,305 | | | $ | (322) | | | $ | (261) | | | $ | 722 | | | Derivatives liabilities | $ | 1,747 | | | $ | (111) | | | $ | 1,636 | | | $ | (322) | | | $ | (14) | | | $ | 1,300 | |
(1)The balances as of December 31, 2025 and September 30, 2026 were related to derivatives allowed to be net settled in accordance with our master netting agreements.
|